Rom S Leidner

15PUBLICATIONS
132CO-AUTHORS
Interactive narrativeImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 26, 2026
TRIALSCOPE - A Framework for Clinical Trial Simulation from Real-World Data.

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Aug 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Robert L Ferris, Rom S Leidner, Christine H Chung

|Jan 06, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

Juanita Lopez, Thomas Powles, Fadi Braiteh

|Nov 12, 2024
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System.

Alexa K Dowdell, Ryan C Meng, Ann Vita

|Oct 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Francis P Worden, Evan Pisick, Michael Rothe

Pageof 3

Frequent Collaborators

3 joint publications

Richard B Bell

3 joint publications

Brian Piening

2 joint publications

Hoifung Poon

2 joint publications

Robert L Ferris